ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer

International Journal of Cancer

Volumn 84, Issue 1, 1999, Pages 24-27

  Graber, Hans U ^a   Friess, Helmut ^a   Kaufmann, Brigitte ^a   Willi, Doris ^a   Zimmermann, Arthur ^a   Korc, Murray ^b   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETACELLULIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GENE PRODUCT; MESSENGER RNA; NEU DIFFERENTIATION FACTOR; PROTEIN TYROSINE KINASE; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MESSENGER RNA SYNTHESIS; METASTASIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 0032942803     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990219)84:1<24::AID-IJC5>3.0.CO;2-2     Document Type: Article

References (21)

1. ALMOGUERA, C., SHIBATA, D., FORRESTER, K., MARTIN, J., ARNHEIM, N. and PERUCHO, M., Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53, 549-554 (1988).
2. BARTON, C.M., STADDON, S.L., HUGHES, C.M., HALL, P.A., O'SULLIVAN, C., KLOPPEL, G., THEIS, B., RUSSELL, R.C., NEOPTOLEMOS, J., WILLIAMSON, R.C., LANE, D.P. and LEMOINE, N.R., Abnormalities of the p53 tumour suppressor gene in human pancreatic. Brit. J. Cancer, 64, 1076-1082 (1991).
3. CARRAWAY, K.L. and CANTLEY, L.C., A Neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell, 78, 5-8 (1994).
4. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
5. DUHL, D.M., GILLESPIE, D.D. and SULSER, F., Ethidium bromide fluorescence of 28S ribosomal RNA can be used to normalize samples in Northern or dot blots when analyzing small drug-induced changes in specific mRNA. J. Neurosci. Methods, 42, 211-218 (1992).
6. FRIESS, H., YAMANAKA, Y., BÜCHLER, M., BEGER, H.G., KOBRIN, M.S., BALDWIN, R.L. and KORC, M., Enhanced expression of type II transforming growth factor β receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res., 53, 2704-2707 (1993a).
7. FRIESS, H., YAMANAKA, Y., BÜCHLER, M.W., EBERT, M., BEGER, H.G., GOLD, L.I. and KORC, M., Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology, 105, 1846-1856 (1993b).
8. FRIESS, H., YAMANAKA, Y., BÜCHLER, M.W., KOBRIN, M.S., TAHARA, E. and KORC, M., CRIPTO, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis. Int. J. Cancer, 56, 668-674 (1994).
9. FRIESS, H., YAMANAKA, Y., KOBRIN, M.S., DO, A.D., BÜCHLER, M.W. and KORC, M., Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. Clin. Cancer Res., 1, 1413-1420 (1995).
10. GANSAUGE, F., GANSAUGE, S., SCHMIDT, E., MÜLLER, J. and BEGER, H.G., Prognostic significance of molecular alterations in human pancreatic carcinoma - an immunohistochemical study. Langenbeck's Arch. Surg., 383, 152-155 (1998).
11. GEBHARDT, A., PETERS, A., GERDING, D. and NIENDORF, A., Rapid quantitation of mRNA species in ethidium bromide-stained gels of competitive RT-PCR products. J. Lipid Res., 35, 976-981 (1994).
12. GUDJONSSON, B., Cancer of the pancreas, 50 years of surgery. Cancer, 60, 2284-2303 (1987).
13. KORC, M., CHANDRASEKAR, B., YAMANAKA, Y., FRIESS, H., BÜCHLER, M.W. and BEGER, H.G., Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J. clin. Invest., 90, 1352-1360 (1992).
14. MURPHY, L.D., HERZOG, C.E., RUDICK, J.B., FOJO, A.T. and BATE, S.E., Use of polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry, 29, 10351-10356 (1990).
15. erbB4, a fourth member of the epidermal growth factor family. Proc. nat. Acad. Sci. (Wash.), 90, 1746-1750 (1993).
16. RAPPOLEE, D.A., MARK, D., BANDA, M.J. and WERB, Z., Wound macrophages express TGF-α and other growth factors in vivo: analysis with mRNA phenotyping. Science, 241, 708-712 (1988).
17. RIESE, D.J., II, BERMINGHAM, Y., VAN RAAIJ, T.M., BUCKLEY, S., PLOWMAN, G.D. and STERN, D.F., Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene, 12, 345-353 (1996).
18. TZAHAR, E., LEVKOWITZ, G., KARUNAGARAN, D., YI, L., PELES, E., LAVI, S., CHANG, D., LIU, N., YAYON, A., WEN, D. and YARDEN, Y., ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu Differentiation Factor/Heregulin isoforms. J. biol. Chem., 269, 25226-25233 (1994).
19. VECCHI, M., BAULIDA, J. and CARPENTER, G., Selective cleavage of the heregulin receptor erbB-4 by protein kinase C activation. J. biol. Chem., 271, 18989-18995 (1996).
20. YAMANAKA, Y., FRIESS, H., KOBRIN, M.S., BÜCHLER, M.W., BEGER, H.G. and KORC, M., Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res., 13, 565-569 (1993a).
21. YAMANAKA, Y., FRIESS, H., KOBRIN, M.S., BÜCHLER, M.W., KUNZ, J., BEGER, H.G. and KORC, M., Overexpression of HER2/neu oncogene in human pancreatic. Hum. Pathol., 24, 1127-1134 (1993b).